About the Summit
The PARP & DDR Inhibitors Summit 2020 gathers the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development. This meeting is the perfect opportunity to gain cutting-edge insights from industry leaders on PARP inhibitor development, creating best-in-class therapeutics, over-riding resistance and identifying novel synthetic lethal pathways to exploit cancer survival mechanisms.
Step out of the office and into a meeting tailored to your niche. Round table talks, panel discussion and networking provide a unique opportunity for open conversation with industry leaders to accelerate your DDR success.
Gain Unique Insights into the Key Issues Facing the Industry
Leverage Therapeutic Combinations
Identify Patient Populations
Expand Drug Efficacy to Wider Indications
Create Pathways to Over-Ride Resistance
Analyze the Emerging DDR Landscape